Organization of Follow-Up Care for Uterine Leiomyoma: Regulatory Guidelines and Outpatient Practice Realities
USMU Medical Bulletin · 30.06.2026 · 11 (2)
DOI: 10.52420/usmumb.11.2.e00229 ↗Kurz gefasst
Leitlinie in der Zeitschrift USMU Medical Bulletin, online erschienen am 30.06.2026. Verfasst von Marina V. Koval und 2 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Uterine leiomyoma is the most common benign tumor of the female reproductive system, affecting up to 70 % of women in the population. New regulatory documents increase the requirements for the organization of follow-up care for patients with uterine leiomyoma. Objective is to substantiate measures aimed at optimizing follow-up care for patients with uterine leiomyoma based on an analysis of current practice and new regulatory requirements.
Methods
A retrospective descriptive study was conducted at antenatal clinics in Ekaterinburg. A total of 100 follow-up monitoring records (Form No. 030/u), outpatient medical records (Form No. 025/u), and registration logs for 2023–2024 were analyzed. Descriptive statistical methods were used, including absolute numbers, proportions, and mean ± standard deviation.
Results
Follow-up care coverage among patients with uterine leiomyoma was 72 %, while 28 % of women were not included in systematic monitoring. Violations of regulatory waiting times for scheduled ultrasound examination were recorded in 24 % of cases. The FIGO classification was absent in 85 % of outpatient records. Ferritin testing was performed in only 28 % of patients. Mild anemia was detected in 30 %. Surgical treatment was performed in 24% of women; uterus-sparing procedures accounted for 16 % of the total sample, while radical surgery was performed in 8 patients.
Conclusion
The main problems in the organization of follow-up care were incomplete medical monitoring coverage, non-compliance with the timeframes for ultrasound diagnostics, low frequency of ferritin testing, and insufficient use of the FIGO classification. To improve the effectiveness of outpatient follow-up care, the introduction of mandatory fields in medical information systems for recording the FIGO fibroid type and serum ferritin level, the implementation of an active patient recall system, and the development of a regional standard operating procedure for follow-up care of women with uterine leiomyoma are proposed.
Zitieren
APA
Koval, M. V., Sevostyanova, O. Y., & Shakirova, V. V. (2026). Organization of Follow-Up Care for Uterine Leiomyoma: Regulatory Guidelines and Outpatient Practice Realities. USMU Medical Bulletin, 11(2). https://doi.org/10.52420/usmumb.11.2.e00229
Vancouver
Koval MV, Sevostyanova OY, Shakirova VV. Organization of Follow-Up Care for Uterine Leiomyoma: Regulatory Guidelines and Outpatient Practice Realities. USMU Medical Bulletin. 2026;11(2). doi:10.52420/usmumb.11.2.e00229
BibTeX
@article{Koval2026,
author = {Koval, Marina V. and Sevostyanova, Olga Yu. and Shakirova, Victoria V.},
title = {Organization of Follow-Up Care for Uterine Leiomyoma: Regulatory Guidelines and Outpatient Practice Realities},
journal = {USMU Medical Bulletin},
year = {2026},
volume = {11},
number = {2},
doi = {10.52420/usmumb.11.2.e00229}
}
EUVIMED